With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Serious Morbidity and Financial Outcomes Among Pediatric Cancer Survivors||Fred Hutchinson Cancer Research Center / Beth Mueller, PhD||Epidemiology Grants||2014||Washington|
|The Role of DNA Methylation in Pediatric Cancer||Fred Hutchinson Cancer Research Center / Scott Diede||Young Investigator Grants||2010||Washington|
|Optimizing Bispecific Antibody Therapy for Acute Leukemias||Fred Hutchinson Cancer Research Center / Roland Walter, MD, PhD & James Olson, MD, PhD||Innovation Grants||2015||Washington|
|Engineering A Graft Versus Leukemia Effect into Cord Blood Transplant for Acute Lymphoblastic Leukemia||Fred Hutchinson Cancer Research Center / Rebecca Gardner||Young Investigator Grants||2011||Washington|
|Niche for in Vitro Generation of Hematopoietic Stem Cells from Pluripotent Stem Cells||Fred Hutchinson Cancer Research Center / Brandon Hadland, MD, PhD||Young Investigator Grants||2014||Washington|
|Exploiting the Potential of Bromodomain Inhibitors in Ewing Sarcoma||Seattle Children's Hospital / Shireen Ganapathi, MD||Young Investigator Grants||2021||Washington|
|Delivering on the Promise of Germline Genetic Testing for RUNX1 Variants||University of Washington, Seattle / Abbye McEwen||RUNX1 Early Career Investigator Grants||2022||Washington|
|Use sophisticated approaches to optimize the effectiveness of current chemotherapy agents, and to develop novel chemotherapy agents||Seattle Children's Hospital and Regional Medical Center / Julie Park, MD||Phase I/II Infrastructure Grants||2006||Washington|
|Immuno-therapeutic Targeting of CD56 in CBA2T3/GLIS2-AML in Children||Fred Hutchinson Cancer Research Center / Soheil Meshinchi, MD/PhD||Reach Grants||2018||Washington|
|Improving Development of and Patient Access to Early Phase Pediatric Cancer Clinical Trials||Seattle Children's Hospital and Regional Medical Center / Russ Geyer||Phase I/II Infrastructure Grants||2010||Washington|